• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估非酒精性脂肪性肝病并进行脂肪定量的非侵入性成像方法:综述

Non-Invasive Imaging Methods to Evaluate Non-Alcoholic Fatty Liver Disease with Fat Quantification: A Review.

作者信息

Jang Weon, Song Ji Soo

机构信息

Department of Radiology, Jeonbuk National University Medical School and Hospital, 20 Geonji-ro, Deokjin-gu, Jeonju 54907, Jeonbuk, Republic of Korea.

Research Institute of Clinical Medicine, Jeonbuk National University, Jeonju 54907, Jeonbuk, Republic of Korea.

出版信息

Diagnostics (Basel). 2023 May 25;13(11):1852. doi: 10.3390/diagnostics13111852.

DOI:10.3390/diagnostics13111852
PMID:37296703
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10252963/
Abstract

Hepatic steatosis without specific causes (e.g., viral infection, alcohol abuse, etc.) is called non-alcoholic fatty liver disease (NAFLD), which ranges from non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH), fibrosis, and NASH-related cirrhosis. Despite the usefulness of the standard grading system, liver biopsy has several limitations. In addition, patient acceptability and intra- and inter-observer reproducibility are also concerns. Due to the prevalence of NAFLD and limitations of liver biopsies, non-invasive imaging methods such as ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI) that can reliably diagnose hepatic steatosis have developed rapidly. US is widely available and radiation-free but cannot examine the entire liver. CT is readily available and helpful for detection and risk classification, significantly when analyzed using artificial intelligence; however, it exposes users to radiation. Although expensive and time-consuming, MRI can measure liver fat percentage with magnetic resonance imaging proton density fat fraction (MRI-PDFF). Specifically, chemical shift-encoded (CSE)-MRI is the best imaging indicator for early liver fat detection. The purpose of this review is to provide an overview of each imaging modality with an emphasis on the recent progress and current status of liver fat quantification.

摘要

无特定病因(如病毒感染、酗酒等)的肝脂肪变性称为非酒精性脂肪性肝病(NAFLD),其范围从非酒精性脂肪肝(NAFL)到非酒精性脂肪性肝炎(NASH)、纤维化以及NASH相关肝硬化。尽管标准分级系统有用,但肝活检存在一些局限性。此外,患者的接受度以及观察者间和观察者内的可重复性也是问题。由于NAFLD的患病率以及肝活检的局限性,能够可靠诊断肝脂肪变性的非侵入性成像方法,如超声检查(US)、计算机断层扫描(CT)和磁共振成像(MRI)发展迅速。超声检查广泛可用且无辐射,但无法检查整个肝脏。CT易于获得,有助于检测和风险分类,尤其是在使用人工智能进行分析时;然而,它会使使用者受到辐射。磁共振成像虽然昂贵且耗时,但可以通过磁共振成像质子密度脂肪分数(MRI-PDFF)测量肝脏脂肪百分比。具体而言,化学位移编码(CSE)-MRI是早期肝脏脂肪检测的最佳成像指标。本综述的目的是概述每种成像方式,重点是肝脏脂肪定量的最新进展和现状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef9/10252963/448989f9ac08/diagnostics-13-01852-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef9/10252963/e00d589bb686/diagnostics-13-01852-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef9/10252963/0fde9c9a3d63/diagnostics-13-01852-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef9/10252963/32c92f3f21d7/diagnostics-13-01852-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef9/10252963/c694dcabd671/diagnostics-13-01852-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef9/10252963/6d0988388863/diagnostics-13-01852-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef9/10252963/1cd8a7bc5075/diagnostics-13-01852-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef9/10252963/448989f9ac08/diagnostics-13-01852-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef9/10252963/e00d589bb686/diagnostics-13-01852-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef9/10252963/0fde9c9a3d63/diagnostics-13-01852-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef9/10252963/32c92f3f21d7/diagnostics-13-01852-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef9/10252963/c694dcabd671/diagnostics-13-01852-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef9/10252963/6d0988388863/diagnostics-13-01852-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef9/10252963/1cd8a7bc5075/diagnostics-13-01852-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef9/10252963/448989f9ac08/diagnostics-13-01852-g007.jpg

相似文献

1
Non-Invasive Imaging Methods to Evaluate Non-Alcoholic Fatty Liver Disease with Fat Quantification: A Review.用于评估非酒精性脂肪性肝病并进行脂肪定量的非侵入性成像方法:综述
Diagnostics (Basel). 2023 May 25;13(11):1852. doi: 10.3390/diagnostics13111852.
2
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.对肥胖症手术候选者的肝脂肪变性分级及非酒精性脂肪性肝炎检测中瞬时弹性成像、磁共振成像和血清评分的前瞻性比较
JHEP Rep. 2021 Sep 30;3(6):100381. doi: 10.1016/j.jhepr.2021.100381. eCollection 2021 Dec.
3
MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends.MR 定量生物标志物在非酒精性脂肪性肝病中的应用:技术进展与未来趋势。
Quant Imaging Med Surg. 2013 Aug;3(4):192-5. doi: 10.3978/j.issn.2223-4292.2013.08.01.
4
Liver fat quantification: where do we stand?肝脏脂肪定量:我们处于什么位置?
Abdom Radiol (NY). 2020 Nov;45(11):3386-3399. doi: 10.1007/s00261-020-02783-1. Epub 2020 Oct 6.
5
Quantification of Liver Fat by MRI-PDFF Imaging in Patients with Suspected Non-alcoholic Fatty Liver Disease and Its Correlation with Metabolic Syndrome, Liver Function Test and Ultrasonography.磁共振成像-质子密度脂肪分数成像对疑似非酒精性脂肪性肝病患者肝脏脂肪的定量分析及其与代谢综合征、肝功能检查和超声检查的相关性
J Clin Exp Hepatol. 2021 Sep-Oct;11(5):586-591. doi: 10.1016/j.jceh.2020.11.004. Epub 2020 Dec 1.
6
Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.非酒精性脂肪性肝炎患者的 MRE、MRI-PDFF 与肝组织学的纵向相关性:selonsertib 二期临床试验数据分析。
J Hepatol. 2019 Jan;70(1):133-141. doi: 10.1016/j.jhep.2018.09.024. Epub 2018 Oct 4.
7
A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.磁共振成像质子密度脂肪分数和磁共振波谱测定的肝脏脂肪含量与非酒精性脂肪性肝病肝脏组织学的比较
Acta Radiol. 2016 Mar;57(3):271-8. doi: 10.1177/0284185115580488. Epub 2015 Apr 8.
8
Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.应用定量超声评估非酒精性脂肪性肝病患者的肝脂肪变
Radiology. 2020 Apr;295(1):106-113. doi: 10.1148/radiol.2020191152. Epub 2020 Feb 4.
9
Effect of pegbelfermin on NASH and fibrosis-related biomarkers and correlation with histological response in the FALCON 1 trial.聚乙二醇化贝佛明对非酒精性脂肪性肝炎(NASH)及纤维化相关生物标志物的影响以及与FALCON 1试验组织学反应的相关性
JHEP Rep. 2023 Jan 7;5(4):100661. doi: 10.1016/j.jhepr.2022.100661. eCollection 2023 Apr.
10
Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD.非酒精性脂肪性肝病患者的肝脏组织学与新型磁共振成像的相关性 - MRI 可准确量化非酒精性脂肪性肝病患者的肝脂肪变性。
Aliment Pharmacol Ther. 2012 Jul;36(1):22-9. doi: 10.1111/j.1365-2036.2012.05121.x. Epub 2012 May 3.

引用本文的文献

1
Assessing the impact of liver fat fraction on portal hemodynamics in nonalcoholic fatty liver disease using MRI proton density fat fraction and MRI 4D Flow.使用MRI质子密度脂肪分数和MRI四维血流评估非酒精性脂肪性肝病中肝脏脂肪分数对门静脉血流动力学的影响。
Front Med (Lausanne). 2025 Aug 7;12:1620649. doi: 10.3389/fmed.2025.1620649. eCollection 2025.
2
Magnetic resonance evaluation of three-dimensional liver fat fraction by hepatitis C status and associations with inflammatory cytokines.丙型肝炎状态对肝脏三维脂肪分数的磁共振评估及其与炎性细胞因子的关联
PLoS One. 2025 Jul 23;20(7):e0327668. doi: 10.1371/journal.pone.0327668. eCollection 2025.
3

本文引用的文献

1
Liver fat quantification in photon counting CT in head to head comparison with clinical MRI - First experience.光子计数CT肝脏脂肪定量与临床MRI的直接比较——初步经验
Eur J Radiol. 2023 Apr;161:110734. doi: 10.1016/j.ejrad.2023.110734. Epub 2023 Feb 9.
2
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population.通过VCTE测定的CAP和LSM是美国成年人群全因死亡率的独立预测因素。
Hepatology. 2023 Apr 1;77(4):1241-1252. doi: 10.1097/HEP.0000000000000023. Epub 2023 Jan 3.
3
Two-dimensional Shear-Wave Elastography and US Attenuation Imaging for Nonalcoholic Steatohepatitis Diagnosis: A Cross-sectional, Multicenter Study.
AI-based Hepatic Steatosis Detection and Integrated Hepatic Assessment from Cardiac CT Attenuation Scans Enhances All-cause Mortality Risk Stratification: A Multi-center Study.
基于人工智能的心脏CT衰减扫描检测肝脂肪变性及综合肝脏评估可增强全因死亡风险分层:一项多中心研究
medRxiv. 2025 Jun 11:2025.06.09.25329157. doi: 10.1101/2025.06.09.25329157.
4
Role of Fasting in the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Systematic Review of Clinical Trials.禁食在非酒精性脂肪性肝病(NAFLD)管理中的作用:一项临床试验的系统评价
Cureus. 2025 May 16;17(5):e84259. doi: 10.7759/cureus.84259. eCollection 2025 May.
5
Altered Hepatic Metabolism in Down Syndrome.唐氏综合征患者肝脏代谢的改变
bioRxiv. 2025 May 31:2025.05.27.656393. doi: 10.1101/2025.05.27.656393.
6
Effectiveness of body roundness index for the prediction of nonalcoholic fatty liver disease: a systematic review and meta-analysis.身体圆润度指数预测非酒精性脂肪性肝病的有效性:一项系统评价和荟萃分析
Lipids Health Dis. 2025 Mar 27;24(1):117. doi: 10.1186/s12944-025-02544-3.
7
Evaluating Pediatric NAFLD with Controlled Attenuation Parameter: A Comprehensive Narrative Review.使用受控衰减参数评估儿童非酒精性脂肪性肝病:一项全面的叙述性综述。
Diagnostics (Basel). 2025 Jan 27;15(3):299. doi: 10.3390/diagnostics15030299.
8
Correlation between hepatic steatosis severity diagnosed by ultrasound and metabolic indexes in elderly patients with MAFLD.老年MAFLD患者超声诊断的肝脂肪变性严重程度与代谢指标的相关性
Front Med (Lausanne). 2025 Jan 7;11:1467773. doi: 10.3389/fmed.2024.1467773. eCollection 2024.
9
Association between non-alcoholic fatty liver disease and progression of abdominal aortic aneurysm: a multicenter study.非酒精性脂肪性肝病与腹主动脉瘤进展之间的关联:一项多中心研究。
BMC Med Imaging. 2025 Jan 20;25(1):24. doi: 10.1186/s12880-025-01559-7.
10
The correlation between metabolic dysfunction-associated steatotic liver disease (MASLD) grades and hemodynamic alterations of the portal, hepatic, and splenic vein and spleen size.代谢功能障碍相关脂肪性肝病(MASLD)分级与门静脉、肝静脉、脾静脉血流动力学改变及脾脏大小之间的相关性。
J Ultrasound. 2024 Nov 13. doi: 10.1007/s40477-024-00965-x.
二维剪切波弹性成像和超声衰减成像在非酒精性脂肪性肝炎诊断中的应用:一项横断面、多中心研究。
Radiology. 2022 Oct;305(1):118-126. doi: 10.1148/radiol.220220. Epub 2022 Jun 21.
4
Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD.应用 MRI 质子密度脂肪分数作为参考标准,对疑似患有非酒精性脂肪性肝病的患者进行肝脏脂肪定量超声与受控衰减参数的直接比较。
Radiology. 2022 Jul;304(1):75-82. doi: 10.1148/radiol.211131. Epub 2022 Mar 29.
5
Detection of fatty liver using virtual non-contrast dual-energy CT.使用虚拟非对比双能 CT 检测脂肪肝。
Abdom Radiol (NY). 2022 Jun;47(6):2046-2056. doi: 10.1007/s00261-022-03482-9. Epub 2022 Mar 19.
6
Assessment of hepatic steatosis based on virtual non-contrast computed tomography: Initial experiences with a photon counting scanner approved for clinical use.基于虚拟非对比 CT 的肝脏脂肪变性评估:临床应用获批的光子计数 CT 的初步经验。
Eur J Radiol. 2022 Apr;149:110185. doi: 10.1016/j.ejrad.2022.110185. Epub 2022 Jan 31.
7
US Attenuation for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative.美国肝脏脂肪定量衰减校正:AIUM-RSNA QIBA 脉冲回波定量超声倡议。
Radiology. 2022 Mar;302(3):495-506. doi: 10.1148/radiol.210736. Epub 2022 Jan 25.
8
Quantitative Evaluation of Hepatic Steatosis Using Advanced Imaging Techniques: Focusing on New Quantitative Ultrasound Techniques.利用先进的影像学技术对肝脂肪变性进行定量评估:重点关注新的定量超声技术。
Korean J Radiol. 2022 Jan;23(1):13-29. doi: 10.3348/kjr.2021.0112.
9
Utility of Ultrasound-Guided Attenuation Parameter for Grading Steatosis With Reference to MRI-PDFF in a Large Cohort.超声引导衰减参数在大样本中的 MRI-PDFF 对脂肪变性分级的效用。
Clin Gastroenterol Hepatol. 2022 Nov;20(11):2533-2541.e7. doi: 10.1016/j.cgh.2021.11.003. Epub 2021 Nov 10.
10
A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease.一项关于非酒精性脂肪性肝病中心血管疾病全球患病率、危险因素和筛查的荟萃分析。
Clin Gastroenterol Hepatol. 2022 Nov;20(11):2462-2473.e10. doi: 10.1016/j.cgh.2021.09.021. Epub 2021 Sep 22.